Thyrocare cancels its analyst call for Q4 & FY26 results scheduled for May 7, 2026, due to unforeseen circumstances.
The cancellation is intimated pursuant to SEBI Listing Regulations (Regulation 30).
The company will communicate a revised schedule for the earnings conference call in due course.